INVESTIGACIÓN

Noticias Más Recientes

  • Alert PyschNews(2017) Adjunctive Ketamine Appears to Reduce Suicidal Thoughts in Depressed Patients for Up to Six Weeks.
  • com (2016) The Future of Ketamine in Psychiatry.
  • Psychology Today (2016) A New Medication on the Horizon for Depression.
  • Neurology Advisor (2016) Ketamine May Be Effective in Major Depression.
  • Economist.com (2016) Novel drugs for depression
  • PRNewswire (2016) New Study Shows Ketamine May Regenerate Brain Cells, Relieving Depression with Lasting Benefit.
  • New York Magazine (2016) What It’s Like to Have Your Severe Depression Treated With a Hallucinogenic Drug.
  • J&J Press Release (2016) Esketamine Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Major Depressive Disorder with Imminent Risk for Suicide.
  • CNN.com (2016) Party Drug Ketamine Closer to Approval for Depression.
  • Nature.com (2016) How Club Drug Ketamine Fights Depression.
  • NPR.com (2015) Depression Treatments Inspired By Club Drug Move Ahead In Tests.
  • Bloomberg (2015) The Ketamine Cure.
  • NPR (2015) Club Drug Ketamine Gains Traction As A Treatment For Depression.
  • Nature.com (2015) Rave drug holds promise for treating depression fast.
  • VICE News (2015) I Used Ketamine to Treat My Depression.
  • NY Times (2014) Special K, a Hallucinogen, Raises Hopes and Concerns as a Treatment for Depression.
  • Scientific American (2013) Is Ketamine the Next Big Depression Drug?
  • Time (2013) ‘Club Drug’ Ketamine Lifts Depression in Hours.
  • NPR.com (2012) Ketamine Relieves Depression By Restoring Brain Connections.
  • PsychiatricNews.com (2012) Ketamine-Induced Optimism: New Hope for the Development of Rapid-Acting Antidepressants.
  • TheAtlantic.com (2012) ‘The Biggest Breakthrough in Depression Research’ in 50 Years Is … Ketamine?
  • National Institutes of Mental Health (2010) Rapid Antidepressant Works by Boosting Brain’s Connections.

Investigaciones y Noticias

Literatura sobre la Terapia para la Depresión

  • Arunogiri S, Keks NA, Hope J. Should ketamine be used for the clinical treatment of depression? Australas Psychiatry. Aug 2016;24(4):381-384.
  • Bobo WV, Voort JL, Croarkin PE, Leung JG, Tye SJ, Frye MA. Ketamine for Treatment-Resistant Unipolar and Bipolar Major Depression: Critical Review and Implications for Clinical Practice. Depress Anxiety. Apr 6 2016.
  • Caddy C, Amit BH, McCloud TL, et al. Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev. 2015(9):CD011612.
  • Fond G, Loundou A, Rabu C, et al. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl). Sep 2014;231(18):3663-3676.
  • Hasselmann HW. Ketamine as antidepressant? Current state and future perspectives. Curr Neuropharmacol. Jan 2014;12(1):57-70.
  • Henderson TA. Practical application of the neuroregenerative properties of ketamine: real world treatment experience. Neural Regen Res. Feb 2016;11(2):195-200.
  • Lapidus KA, Levitch CF, Perez AM, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. Dec 15 2014;76(12):970-976.
  • Messer M, Hailer I. Maintenance ketamine treatment produces long-term recovery from depression. Primary Psychiatry. May 21, 2013.
  • McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med. Mar 2015;45(4):693-704.
  • Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. Oct 2013;170(10):1134-1142.
  • Newport DJ, Carpenter LL, McDonald WM, et al. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. Am J Psychiatry. Oct 2015;172(10):950-966.
  • Niciu MJ, Luckenbaugh DA, Ionescu DF, et al. Clinical predictors of ketamine response in treatment-resistant major depression. J Clin Psychiatry. May 2014;75(5):e417-423.
  • Rasmussen KG, Lineberry TW, Galardy CW, et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. May 2013;27(5):444-450.
  • Singh JB, Fedgchin M, Daly EJ, et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. Apr 8 2016:appiajp201616010037.
  • Solovitch S. Onetime party drug hailed as miracle for treating severe depression. The Washington Post. 2016.
  • Stiles, L. Ketamine may provide lasting relief from depression. Psychiatry Advisor. March, 24 2016.

Literatura sobre la Terapia para el Trastorno por Estrés Postraumático (TEPT)

  • Cassels, C. Ketamine: New potential as rapid PTSD treatment not just for depression anymore? Medscape Medical News. April 17 2014. (Free Medscape login required).
  • Canadian Agency for Drugs and Technologies in Health. Intravenous Ketamine for the Treatment of Mental Health Disorders: A Review of Clinical Effectiveness and Guidelines. Ottawa (ON). Aug 20 2014.
  • Feder A, et al. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder, JAMA Psychiatry. 2014;71(6):681-688.
  • Womble, A. Effects of Ketamine on Major Depressive Disorder in a Patient with Posttraumatic Stress Disorder, AANA J. 2013;81(2):118-119.

Literatura sobre Terapia para el Dolor Crónico

  • Birklein F, O’Neill D, Schlereth T. Complex regional pain syndrome: An optimistic perspective. Neurology. Jan 6 2015;84(1):89-96.
  • Connolly SB, Prager JP, Harden RN. A systematic review of ketamine for complex regional pain syndrome. Pain Med. May 2015;16(5):943-969.
  • Kim M, Cho S, Lee JH. The effects of long-term ketamine treatment on cognitive function in complex regional pain syndrome: A preliminary study. Pain Med. Aug 2016;17(8):1447-1451.
  • Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. Feb 2014;77(2):357-367.
  • O’Brien SL, Pangarkar S, Prager J. The use of ketamine in neuropathic pain. Curr Phys Med Rehabil Rep. 2014;2(2):128-145.
  • Puchalski P, Zyluk A. Results of the treatment of chronic, refractory CRPS with ketamine infusions: a preliminary report. Handchir Mikrochir Plast Chir. Jun 2016;48(3):143-147.
  • Sheehy KA, Muller EA, Lippold C, Nouraie M, Finkel JC, Quezado ZM. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study. BMC Pediatr. 2015;15:198.
  • Xu J, Yang J, Lin P, Rosenquist E, Cheng J. Intravenous therapies for complex regional pain syndrome: A systematic review. Anesth Analg. Mar 2016;122(3):843-856.

Deja de Sufrir…Podemos ayudarte… Llámanos YA.

Consulte con nuestro equipo experimentado en iAche para determinar si el tratamiento con ketamina es adecuado para usted. En el iAche, brindamos terapia de ketamina por vía intravenosa como un tratamiento ambulatorio conveniente

PROMETEMOS A CUIDAR Y ENTREGAR

  • “Hice una serie inicial de 6 tratamientos en un período de dos semanas. ¡Nunca me he sentido mejor en años! Recomendaría este tratamiento a cualquiera que esté luchando contra la depresión.”
    K.T
  • “La ketamina es realmente un tratamiento que cambia la vida. Ahora tengo un nuevo contrato de vida!”
    Anonymous
  • “Fue un cambio total en mi vida. Había sufrido depresión durante 35 años. Logré remisión en ocho horas.”
    D.H
  • “Tuve una sensación de bienestar que me invadió. En lugar de provenir directamente de las infusiones como esperaba, fue por hacer todas estas cosas nuevas que la ketamina me ha permitido hacer.”
    R.S
  • “No podría estar más feliz con los resultados de mi tratamiento. Todos los aspectos de mi depresión, desde la dificultad para pensar bien, hasta la ansiedad, hasta la simple falta de alegría en lo que deberían ser los placeres humanos cotidianos, han mejorado drásticamente.”
    J.W